{"id":"https://openalex.org/W4242500154","doi":"https://doi.org/10.3987/r-1985-01-0198","title":"Synthesis of Tricyclic Compounds Using 2(1H)-Quinoxalinone Derivatives","display_name":"Synthesis of Tricyclic Compounds Using 2(1H)-Quinoxalinone Derivatives","publication_year":1985,"publication_date":"1985-01-01","ids":{"openalex":"https://openalex.org/W4242500154","doi":"https://doi.org/10.3987/r-1985-01-0198"},"language":"en","primary_location":{"id":"doi:10.3987/r-1985-01-0198","doi":"https://doi.org/10.3987/r-1985-01-0198","is_oa":true,"landing_page_url":"https://doi.org/10.3987/r-1985-01-0198","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.3987/r-1985-01-0198","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112223693","display_name":"Kenji Makino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Makino","raw_affiliation_strings":["Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","LTD. Shiraoka, Saitama 349-02, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"LTD. Shiraoka, Saitama 349-02, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046077910","display_name":"Gozyo Sakata","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Gozyo Sakata","raw_affiliation_strings":["Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","LTD. Shiraoka, Saitama 349-02, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"LTD. Shiraoka, Saitama 349-02, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110619453","display_name":"Katsushi Morimoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsushi Morimoto","raw_affiliation_strings":["Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","LTD. Shiraoka, Saitama 349-02, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"LTD. Shiraoka, Saitama 349-02, Japan","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113693986","display_name":"Yoshinori Ochiai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112703","display_name":"Nissan Chemical Corporation (Japan)","ror":"https://ror.org/01skwyh03","country_code":"JP","type":"company","lineage":["https://openalex.org/I4210112703"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshinori Ochiai","raw_affiliation_strings":["Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","LTD. Shiraoka, Saitama 349-02, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biological and Chemical Research Laboratory, Nissan Chemical Ind.,","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"Central Research Institute, Nissan Chemical Ind., LTD. Funabashi, Chiba 274, Japan","institution_ids":["https://openalex.org/I4210112703"]},{"raw_affiliation_string":"LTD. Shiraoka, Saitama 349-02, Japan","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210112703"],"apc_list":null,"apc_paid":null,"fwci":0.5675,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.66306579,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"1","first_page":"198","last_page":"198"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T13160","display_name":"Synthesis and Biological Evaluation","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13876","display_name":"Chemical synthesis and pharmacological studies","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13208","display_name":"Synthesis of heterocyclic compounds","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tricyclic-compounds","display_name":"tricyclic compounds","score":0.9520000219345093},{"id":"https://openalex.org/keywords/quinoxaline-derivatives","display_name":"quinoxaline derivatives","score":0.8510000109672546},{"id":"https://openalex.org/keywords/tricyclazole","display_name":"tricyclazole","score":0.9580000042915344},{"id":"https://openalex.org/keywords/heterocycle-synthesis","display_name":"heterocyclic synthesis","score":0.9139999747276306}],"concepts":[{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.9663532972335815},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9449957013130188},{"id":"https://openalex.org/C2780362310","wikidata":"https://www.wikidata.org/wiki/Q419930","display_name":"Quinoxaline","level":2,"score":0.7298153042793274},{"id":"https://openalex.org/C24961977","wikidata":"https://www.wikidata.org/wiki/Q225972","display_name":"Bicyclic molecule","level":2,"score":0.4948047995567322},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4853626489639282},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.4118291139602661},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.347917377948761}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3987/r-1985-01-0198","doi":"https://doi.org/10.3987/r-1985-01-0198","is_oa":true,"landing_page_url":"https://doi.org/10.3987/r-1985-01-0198","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3987/r-1985-01-0198","doi":"https://doi.org/10.3987/r-1985-01-0198","is_oa":true,"landing_page_url":"https://doi.org/10.3987/r-1985-01-0198","pdf_url":null,"source":{"id":"https://openalex.org/S27298842","display_name":"Heterocycles","issn_l":"0385-5414","issn":["0385-5414","1881-0942"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","norway-1","poland-40","russia-white-list-4"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HETEROCYCLES","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4256303732","https://openalex.org/W4412065343","https://openalex.org/W2169033374","https://openalex.org/W4412065380","https://openalex.org/W4400157309","https://openalex.org/W2950500921","https://openalex.org/W2395241648","https://openalex.org/W2014186081","https://openalex.org/W1984017079","https://openalex.org/W2949202132"],"abstract_inverted_index":{"Quinoxaline":[0],"derivatives":[1,36],"are":[2],"widely":[3],"used":[4],"as":[5,26,34],"pharmaceutical":[6],"and":[7,37,43],"agricultural":[8],"chemicals.In":[9],"connection":[10],"with":[11],"our":[12],"biological":[13],"studies,":[14],"we":[15],"synthesized":[16],"new":[17],"tricyclic":[18],"compounds":[19],"(Type":[20],"I.":[21],"II,":[22],"D":[23],"l":[24],")":[25],"shown":[27],"in":[28],"Fig.":[29],"1.They":[30],"can":[31],"be":[32],"regarded":[33],"2(1H)quinoxalinone":[35],"quinaxaline":[38],"analogues":[39],"of":[40],"Pyroquilon,":[41],"PP-389":[42],"Tricyclazole.":[44]},"counts_by_year":[],"updated_date":"2026-07-28T07:46:37.118299","created_date":"2022-05-12T00:00:00"}